The Usability, Feasibility, and Tolerability of Virtual Reality for Rehabilitation From COVID-19 (COVRehab)

Radboud University Medical Center

Status

Completed

Conditions

Post Intensive Care Unit Syndrome

Coronavirus

Treatments

Device: Virtual Reality

Study type

Interventional

Funder types

Other

Identifiers

NCT04505761

COVRehab

Details and patient eligibility

About

Patients who receive intensive care are known to be at high risk for physical, psychological, and cognitive impairments, a constellation known as PICS. COVID-19 patients are expected to have high chances of suffering from PICS (PICS-COV) as they frequently require several weeks of intensive care and traditional PICS preventive measures are virtually impossible due to infection control precautions, prone positioning, and deprivation of social contact. To prevent PICS after ICU discharge in COVID-19 patients, physical therapy is recommended. From recent but limited experience it appears that even patients with COVID-19 who have not been admitted to the ICU can suffer from impairments in the same domains and sometimes to a similar degree of severity. Also for these patient group rehabilitation seems warranted.

Yet, the resources needed to provide rehabilitation treatment to COVID-19 patients are inadequate because healthcare systems faced a shortage of high-quality treatment for these impairments already before the COVID-19 crisis emerged. Virtual Reality (VR) provides potential to healthcare practitioners to administer fast, temporary, and tailor-made rehabilitation services at a distance, and offers a solution to address the impending surge of demand for rehabilitation after COVID-19 infection. VR consists of a head mounted display (HMD) that can bring the user by computer-generated visuals into an immersive, realistic multi-sensory environment. Current VR technology is accessible, easy in use for a large audience, and safe in use. There already exist multiple VR applications for providing physical, psychological, and cognitive rehabilitation. These applications have been brought together in a VR suite for rehabilitation after COVID-19. Patients visiting a physiotherapist for rehabilitation from COVID-19 will be asked to participate in this study. They receive a VR HMD for training purposes. This study aims to understand the usability, feasibility, and tolerability of VR for rehabilitation after COVID-19, and to pilot the effectiveness of VR improving the physical ability, mental and cognitive status of patients.

Enrollment

48 patients

Sex

All

Ages

16+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patient has had COVID-19.
Patient has an indication for physical therapy in the context of rehabilitation after COVID-19.
At the day of recruitment, the estimated length of the physical therapy is at least 3 weeks after inclusion.
Patient is willing and able to comply with the study protocol.
Patient is at least 16 years old on the day the informed consent form will be signed.
Patient can read and understand the Dutch language.

Exclusion criteria

The patient is participating in another study interfering with this study.
Patient has difficulties to handle virtual reality:
1. Patient suffers from delirium or acute confusional state.
2. Patient has (a history of) dementia, seizure, or epilepsy.
3. Patient has severe hearing/visual impairment not corrected.
4. The skin of the patient's head or face is not intact (for example head wounds, psoriasis, eczema).
Patient has a high risk of contamination with a therapy resistant micro-organism e.g. MRSA.
Patients suffers from severe anxiety or depression (HADS≥16).
Red flags (see Appendix 1).